6.2.U8 The heart beat is initiated by a group of specialized muscle cells in the right atrium called the sinoatrial node. AND 6.2.U9 The sinoatrial node acts as a pacemaker. AND 6.2.U10 The sinoatrial node sends out an electrical signal that stimulates contraction as it is propagated through the walls of the atria and then the walls of the ventricles. http://www2.estrellamountain.edu/faculty/farabee/Biobk/heartbeat.gif The nervous system does not cause the heart to beat, it can only speed up or slow down the rate of the heartbeat. Myogenic initiation of the contraction means that the heart does not stop beating – it is not a conscious process.

Electrical system of the heart 6.2.U11 The heart rate can be increased or decreased by impulses brought to the heart through two nerves from the medulla of the brain. AND 6.2.U12 Epinephrine increases the heart rate to prepare for vigorous physical activity. http://goo.gl/YeoeJ n.b. adrenalin is also known as epinephrine Electrical system of the heart http://medmovie.com/library_id/7556/topic/cvml_0005a/

6.2.A2 Pressure changes in the left atrium, left ventricle and aorta during the cardiac cycle. SL valves AV valves AV = atrioventricular  tricuspid & bicuspid (mitral) valves SL = semilunar  pulmonary & aortic valves

An electrocardiogram (ECG) is a test that measures the electrical activity of the heartbeat It can be used to determine if electrical activity is normal and it may be used to determine if parts of the heart are too large or overworked. http://www.heart.org/HEARTORG/Conditions/HeartAttack/SymptomsDiagnosisofHeartAttack/Electrocardiogram-ECG-or-EKG_UCM_309050_Article.jsp#.VsXyKtLwudK

http://www.heart.org/HEARTORG/Conditions/HeartAttack/SymptomsDiagnosisofHeartAttack/Electrocardiogram-ECG-or-EKG_UCM_309050_Article.jsp#.VsXyKtLwudK

http://4.bp.blogspot.com/_5Nslwo9F6bI/S_EU-Kcs4DI/AAAAAAAAAg4/5f0VSazrcN4/s1600/ECG+trace+%26+basics.jpg

6.2.A2 Pressure changes in the left atrium, left ventricle and aorta during the cardiac cycle.

Pictured is a cholesterol-filled atherosclerotic coronary artery from a human body. Researchers at the University of Pennsylvania School of Medicine have demonstrated the potential of a new type of therapy for patients who suffer from high cholesterol levels. A new study shows that targeted inhibition of the microsomal triglyceride transfer protein (MTP) is highly effective in reducing cholesterol levels in very high risk patients. http://www.uphs.upenn.edu/news/News_Releases/jan07/MTP-inhibition-reduce-high-cholesterol.htm

6.2.A3 Causes and consequences of occlusion of the coronary arteries. http://www.hhmi.org/biointeractive/obesity/heart_attack.html

6.2.A3 Causes and consequences of occlusion of the coronary arteries. http://www.webmd.com/heart/video/coronary-bypass

6.2.A3 Causes and consequences of occlusion of the coronary arteries.